Evidence map›Paper›PMID 40595365›Full record

ArticleNature2025

Author Correction: Targeting the SHOC2-RAS interaction in RAS-mutant cancers.

Zachary J Hauseman, Frédéric Stauffer, Kim S Beyer, Sandra Mollé, Elena Cavicchioli, Jean-Remy Marchand, Michelle Fodor, Jessica Viscomi, Anxhela Dhembi, Stéphanie Katz and 23 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

33 authors.

Zachary J Hauseman *Novartis BioMedical Research, Cambridge, MA, USA.
Frédéric Stauffer *Novartis BioMedical Research, Basel, Switzerland.
Kim S Beyer *Novartis BioMedical Research, Basel, Switzerland.ORCID http://orcid.org/0000-0002-3047-304X
Sandra MolléNovartis BioMedical Research, Basel, Switzerland.ORCID http://orcid.org/0009-0000-3288-7513
Elena CavicchioliNovartis BioMedical Research, Basel, Switzerland.
Jean-Remy MarchandNovartis BioMedical Research, Basel, Switzerland.ORCID http://orcid.org/0000-0002-8002-9457
Michelle FodorNovartis BioMedical Research, Cambridge, MA, USA.
Jessica ViscomiNovartis BioMedical Research, Cambridge, MA, USA.
Anxhela DhembiNovartis BioMedical Research, Cambridge, MA, USA.
Stéphanie KatzNovartis BioMedical Research, Basel, Switzerland.ORCID http://orcid.org/0009-0006-8730-9351
Beatrice FaggionNovartis BioMedical Research, Basel, Switzerland.
Mylene LanterNovartis BioMedical Research, Basel, Switzerland.
Grainne KerrNovartis BioMedical Research, Basel, Switzerland.ORCID http://orcid.org/0009-0004-4231-518X
Daniela SchildknechtNovartis BioMedical Research, Basel, Switzerland.
Cornelia HandlNovartis BioMedical Research, Basel, Switzerland.
Danilo MaddaloNovartis BioMedical Research, Basel, Switzerland.
Carole Pissot SoldermannNovartis BioMedical Research, Basel, Switzerland.
Jacob BradyNovartis BioMedical Research, Cambridge, MA, USA.
Om ShresthaNovartis BioMedical Research, Cambridge, MA, USA.
Zachary NguyenNovartis BioMedical Research, Cambridge, MA, USA.
Lukas LederNovartis BioMedical Research, Basel, Switzerland.ORCID http://orcid.org/0009-0002-4378-6739
Gregor CremosnikNovartis BioMedical Research, Basel, Switzerland.
Sandra Lopez RomeroNovartis BioMedical Research, Basel, Switzerland.
Ulrich HassiepenNovartis BioMedical Research, Basel, Switzerland.
Travis StamsNovartis BioMedical Research, Cambridge, MA, USA.
Markus LinderNovartis BioMedical Research, Basel, Switzerland.
Giorgio G GalliNovartis BioMedical Research, Basel, Switzerland.ORCID http://orcid.org/0000-0002-9401-060X
Daniel A GuthyNovartis BioMedical Research, Basel, Switzerland.ORCID http://orcid.org/0000-0001-5324-8585
Daniel A KingNovartis BioMedical Research, Cambridge, MA, USA.
Sauveur-Michel MairaNovartis BioMedical Research, Basel, Switzerland.
Claudio R ThomaNovartis BioMedical Research, Cambridge, MA, USA.
Veronika EhmkeNovartis BioMedical Research, Basel, Switzerland. veronika.ehmke@novartis.com.
Luca TordellaNovartis BioMedical Research, Basel, Switzerland. luca.tordella@novartis.com.ORCID http://orcid.org/0000-0002-0542-7834

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40595365
PMCPMC12267047

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.